Trials / Completed
CompletedNCT03374345
Efficacy and Safety of Sipjeondaebo-tang on Korean Patients With Cold Hypersensitivity in the Hands and Feet (SDT)
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Gachon University Gil Oriental Medical Hospital · Academic / Other
- Sex
- Female
- Age
- 19 Years – 59 Years
- Healthy volunteers
- Not accepted
Summary
Gachon University, Gil Oriental Medicine Center
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sipjeondaebo-tang Granule | 3g, three times a day, each taken before or between meals Manufacturing company: HANPOONG PHARM \& FOODS Co. Ltd. |
| DRUG | Placebo | 3g, three times a day, each taken before or between meals Manufacturing company: HANPOONG PHARM \& FOODS Co. Ltd. |
Timeline
- Start date
- 2018-01-31
- Primary completion
- 2019-12-30
- Completion
- 2019-12-30
- First posted
- 2017-12-15
- Last updated
- 2021-09-01
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03374345. Inclusion in this directory is not an endorsement.